Dahlia Biosciences Company
Dahlia Biosciences is the next generation of multiplexed in situ single-cell RNA analysis tools for research and diagnostic applications.
DAHLIA BIOSCIENCES, INC. provides in situ single-cell RNA analysis tools for research and diagnostic applications. The company was founded in 2017 and is headquartered in San Francisco, California.
Technology:
Preventive Diagnostics
Headquarters:
San Francisco
Funding Status:
Seed
Investment Stage:
N/A
Founded Date:
2017
Number Of Exists:
N/A
Employee Number:
1-10
Industry:
Precision Medicine
Investor Type:
N/A